Allergen immunotherapy for asthma: looking "Back to the Future".
Asthma is a heterogeneous chronic syndrome which represents a relevant socioeconomic burden in both adults and children. Global asthma prevalence has been reported to be of approximately 300 million people, with an estimate of increasing figures up to 400 million by 20251 . Among the identified distinct phenotypes and endotypes2 , allergic asthma represents one of the most well-characterized and relevant nosologic entity, with atopy playing a key role in the disease risk, onset and progression. This article is protected by copyright. All rights reserved.